Navigation Links
Mindray Announces First Quarter 2009 Financial Results
Date:5/11/2009

uding non-GAAP gross margin, non-GAAP operating profit, non-GAAP selling expenses, non-GAAP general and administrative expenses, non-GAAP R&D expenses, non-GAAP net income and non-GAAP earnings per share on a basic and fully diluted basis. The Company believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing Mindray's financial performance and liquidity and when planning and forecasting future periods. These non-GAAP operating measures are useful for understanding and assessing Mindray's underlying business performance and operating trends and the Company expects to report operating profit and net income on a non-GAAP basis using a consistent method on a quarterly basis going forward.

The Company computes its non-GAAP financial measures using the same consistent method from quarter to quarter. The Company notes that these measures may not be calculated on the same basis of similar measures used by other companies. Readers are cautioned not to view non-GAAP results on a stand-alone basis or as a substitute for results under GAAP, or as being comparable to results reported or forecasted by other companies, and should refer to the reconciliation of GAAP results with non-GAAP results for the three months period ended March 31, 2008 and 2009, respectively, in the attached financial information.

Cautionary Note Regarding Forward-Looking Statements

This press release contains "forward-looking statements," including those related to the company's market performance, the business outlook for the fiscal year 2009 with respect to net revenues, Non-GAAP EPS, capital expenditure, share based compensation and amortization of intangible assets, the company's ability to grow in various geographic markets, to adapt to changing market environments, to take advantage of cost advantages, and to capture growth opportunities. These statements are not historic
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
2. Mindray to Report First Quarter 2009 Financial Results on May 11, 2009
3. Mindray Medical to Exhibit New Products at 61st China International Medical Equipment Fair
4. Mindray Announces Option Exchange Offer
5. Mindray to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 4, 2009
6. Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009
7. Mindray Announces Preliminary 2008 Operating Results
8. Mindray Medical to Present at the 27th Annual J.P. Morgan Healthcare Conference
9. Mindray Medical to Exhibit at RSNA 2008 in Chicago, from November 30th to December 4th, 2008
10. Mindray Announces 2008 Third Quarter and Nine Months Results
11. Mindray to Report Third Quarter 2008 Financial Results on November 11, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... WASHINGTON,Nov.24/PRNewswire/--TheUnionLaborLifeI...tithasalignedwithVSP(®),()thenation,slargestv...isioninsuranceproductstounions,uniontrustfunds,uni...oraccesspointsofferingservicesincludingcomprehensi...Weunderstandhowimportantqualityeyecareis,"statedBr...
(Date:11/24/2009)... herbal supplement may help ward off peripheral ar...AY, Nov. 24 (HealthDay News) -- Among people aged ...does not prevent heart attacks, stroke or death, a... the popular herbal remedy might help prevent the ... disease, however. , Ginkgo contains nutrients ...
(Date:11/24/2009)...ital death rates didn,t differ greatly between hig..., TUESDAY, Nov. 24 (HealthDay News) -- Do hospita... produce the best results for patients? Maybe not....makes perfect" when it comes to artery-opening pro...ients finds low- and high-volume hospitals perform...
(Date:11/24/2009)...ber 18, 2009 - Oakland, Calif. A study conducted ...cientists identifies a new class of therapeutic ag...ossibly treat colon cancer, the third most deadly ...pid molecules found in soy that research shows may...y, led by Julie Saba, MD, PhD, senior scientist an...
(Date:11/24/2009)... CHICAGO,Nov.24/PRNewswire-USNewswire/--TheAmerica...pleUniversitytotrainnewdentalteammembersaspartofap...unities. ,, TheCommunityDentalHealthCoordinator...unitieswhereresidentshavelimitedaccesstodentalcare...mitedrangeofpreventivedentalcareservices--includin...
Breaking Medicine News(10 mins):Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3Health News:Children's Hospital Oakland scientists discover soy component may be key to fighting colon cancer 2Health News:ADA Launches Community Dental Health Coordinator Pilot Program at Temple University 2
...dical Solutions, Inc. (OTC Bulletin Board: IMSU), ...appointment of Craig W. Lunsman to its board,of di...irector of William,Jamieson Group, LLC, a consulti...sman will act as Chairman of the Company,s,Audit C...
...ine survey administered by the Alliance for the Pr...iagnosed with methicillin-resistant,staphylococcus...formation,on the condition at the time of diagnosi...Most respondents reported being very concerned abo...
...tCall/ - Bradmer Pharmaceuticals Inc.,a biopharmac...ommercialization of cancer therapies, announced to...ecutive Officer of the Company, will present,at th...e III trial for Neuradiab, a treatment for newly d...
...of plastic 3-D glasses and an unearthly blue multi...horror flick -- seems to leap out of the computer ...e director,s fantasy. The horror image is real. , ... of Medicine are mapping parts of the lethal bacte...
...nc. (SPOC) of Stamford, Conn., a Technogenesis Com... and Connecticut Innovations (CI), the states quas...sting and innovation development, have announced t... CI invested in SPOC through its Connecticut BioSe...
...by without progress toward universal coverage, mor...sted, and more damage is done to an already,weaken...er and the,president pro tem introduced their heal...l Californians. We had a,Republican governor and D...
Other Medicine News:Health News:Impact Medical Solutions Announces Appointment of New Director 2Health News:Impact Medical Solutions Announces Appointment of New Director 3Health News:New Survey Finds that over Half of MRSA Patients Report Having Received No Information about the Disease from Health Care Providers 2Health News:New Survey Finds that over Half of MRSA Patients Report Having Received No Information about the Disease from Health Care Providers 3Health News:Bradmer to present at Rodman & Renshaw Healthcare Conference 2Health News:Northwestern exposing most deadly infectious diseases in 3-D 2Health News:Northwestern exposing most deadly infectious diseases in 3-D 3Health News:Northwestern exposing most deadly infectious diseases in 3-D 4Health News:SPOC, Inc. announces completion of $300,000 follow-on investment by Connecticut Innovations 2Health News:Statement by Bruce Bodaken, Chairman & CEO, Blue Shield of California 2
(Date:11/24/2009)...RNewswire-FirstCall/--CardioGenicsHoldingsInc.(OTC...ctstargetingtheimmunoassaysegmentoftheIVDtestingma...progressingtothenextphaseofthecommercializationofC...ds("Beads"). ,, PertheagreementwithMerckChimiet...MerckChimiewithitsproprietarysilvercoatedparamagne...
(Date:11/24/2009)...irstCall/--NeurocrineBiosciences,Inc.(Nasdaq: NBIX...xecutiveOfficerofNeurocrineBiosciences,willbeprese...ceinNewYork. ,, ThelivepresentationtakesplaceTu...p.m.PacificTime(PT).Thepresentationwillbesimultane...t http://www.neurocrine.com . ,, Ifyouareunable...
(Date:11/24/2009)...swire-FirstCall/--IsisPharmaceuticals,Inc.(Nasdaq:...uncedthatmanagementwillpresentacompanyoverviewatPi...y,December1,2009,at10:30a.m.ETatTheNewYorkPalaceHo...eavailableonthe"Investors&Media"sectionoftheCo...sentationwillbeavailableontheIsisWebsitewithin48ho...
Breaking Medicine Technology:CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 3With a Broken Hip Comes Higher Risk for Dying 53648 1With a Broken Hip Comes Higher Risk for Dying 53648 2With a Broken Hip Comes Higher Risk for Dying 53648 3BD and Direct Relief International Team Up to Provide Free Diabetes Insulin Injection Products to Americans Impacted by the Economic Downturn 53643 1BD and Direct Relief International Team Up to Provide Free Diabetes Insulin Injection Products to Americans Impacted by the Economic Downturn 53643 2BD and Direct Relief International Team Up to Provide Free Diabetes Insulin Injection Products to Americans Impacted by the Economic Downturn 53643 3BD and Direct Relief International Team Up to Provide Free Diabetes Insulin Injection Products to Americans Impacted by the Economic Downturn 53643 4Class Action Notice for Minnesota Light Cigarette Litigation From Lommen Abdo Cole King 26 Stageberg P A 53638 1Class Action Notice for Minnesota Light Cigarette Litigation From Lommen Abdo Cole King 26 Stageberg P A 53638 2Class Action Notice for Minnesota Light Cigarette Litigation From Lommen Abdo Cole King 26 Stageberg P A 53638 3
...une 30 deCODE genetics,(Nasdaq: DCGN ) today ann...inical pharmacology study of DG041, the company,s ...prostaglandin E2, developed as a,next-generation o...thrombosis without increasing bleeding risk. The p...mpared the effects on platelet activation and,blee...
... June 30 XTL,Biopharmaceuticals Ltd. (Nasdaq: XT...ted patient randomization into its Phase 2b study ...uptake inhibitor (SNRI) -- for the,treatment of di...zed into,the study. Based on the completion of ran...atient complete the study in the next 4 months., ...
Other Medicine Technology:DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin 2DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin 3DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin 4XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain 2XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain 3
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: